Pancreatic Cancer Research

ResearcherAsahikawa Medical UniversityActive in the last 2 years

Kenji Takahashi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6166-6848; OpenAlex author ID A5101897577, A5121192409. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 3 papers

Papers 9

  1. Extracellular vesicle-encapsulated microRNA-425 promotes tumor development and serves as a biomarker for pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00535-026-02382-9↗
  2. Liquid Biopsy for Early Pancreatic Cancer Detection: Why Has It Not Yet Worked? Co-author DOI 10.3390/cancers18030525↗
  3. Thiol methyltransferase METTL7B coordinates lipid metabolism and promotes tumor progression in pancreatic cancer Co-author DOI 10.64898/2026.04.09.717095↗
  4. Highly multiplexed digital PCR assay for simultaneous quantification of variant allele frequencies and copy number alterations of KRAS and GNAS in pancreatic c… Co-author DOI 10.1002/1878-0261.70011↗
  5. Liquid Biopsy for Pancreatic Cancer by Serum Extracellular Vesicle-Encapsulated Long Noncoding RNA HEVEPA. Co-author DOI 10.1097/mpa.0000000000002315↗
  6. Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway. Co-author DOI 10.1007/s00535-021-01846-4↗
  7. Long Non-Coding RNAs in Epithelial-Mesenchymal Transition of Pancreatic Cancer. Co-author DOI 10.3389/fmolb.2021.717890↗
  8. Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer. Co-author DOI 10.1111/cas.14232↗
  9. The Interaction Between Long Non-coding RNA HULC and MicroRNA-622 via Transfer by Extracellular Vesicles Regulates Cell Invasion and Migration in Human Pancrea… Co-author DOI 10.3389/fonc.2020.01013↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yusuke Mizukami · 7 shared papers, 2021–2026 · strength 1.51
  2. Mikihiro Fujiya · 5 shared papers, 2021–2026 · strength 0.99
  3. Hidemasa Kawabata · 4 shared papers, 2022–2026 · strength 0.74
  4. Toshikatsu Okumura · 4 shared papers, 2021–2026 · strength 0.66
  5. Yohei Kitano · 4 shared papers, 2020–2026 · strength 0.62
  6. Hiroki Sato · 3 shared papers, 2022–2025 · strength 0.52
  7. Kazuya Koyama · 3 shared papers, 2020–2026 · strength 0.51
  8. Andrew Scott Liss · 2 shared papers, 2022–2025 · strength 0.35
  9. Krushna Chandra Patra · 1 shared paper, 2026 · strength 0.33
  10. Tetsuhiro Okada · 2 shared papers, 2022–2026 · strength 0.33
  11. Kentaro Kawata · 1 shared paper, 2026 · strength 0.28
  12. Shuhei Mitsutomi · 1 shared paper, 2026 · strength 0.28
  13. Junko Tanaka · 1 shared paper, 2025 · strength 0.24
  14. Takahide Yokoi · 1 shared paper, 2025 · strength 0.24
  15. Hiroaki Konishi · 1 shared paper, 2022 · strength 0.11
  16. Satoshi Fujii · 1 shared paper, 2020 · strength 0.11
  17. Tsuguhito Ota · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.